Expiring UK Public Contracts: Retender Radar
Explore UK public contracts by expiry date, with buyers, incumbent suppliers and extension options. Estimated end dates are labelled; expiry does not guarantee a new tender.
Contracts ending in the all future end dates
Page 161 · 15 contracts on this page · more available
Contracts Finder rows are not in this view: sector, region, buyer type, agreement type, extension, a boolean keyword and the annual sort apply to Find a Tender.
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Bayer Plc · Last contest: 60 bids
- Published value
- £395kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Stirling Anglian Pharmaceuticals Ltd · Last contest: 60 bids
- Published value
- £383kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Takeda UK Limited · Last contest: 60 bids
- Published value
- £348kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Sandoz · Last contest: 60 bids
- Published value
- £289kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Pfizer Ltd · Last contest: 60 bids
- Published value
- £281kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Sun Pharma UK Ltd · Last contest: 60 bids
- Published value
- £248kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Biogen Idec Ltd · Last contest: 60 bids
- Published value
- £225kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Recordati Pharmaceuticals Ltd · Last contest: 60 bids
- Published value
- £196kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Amarox Limited · Last contest: 60 bids
- Published value
- £193kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Viatris UK Healthcare Ltd · Last contest: 60 bids
- Published value
- £157kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Kent Pharma Ltd · Last contest: 60 bids
- Published value
- £150kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Flexipharm Austrading Limited · Last contest: 60 bids
- Published value
- £149kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Teva UK Ltd · Last contest: 60 bids
- Published value
- £97kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Zentiva Pharma UK Ltd · Last contest: 60 bids
- Published value
- £79kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
- Estimated end · in 3,298 daysFind a TenderCall-off
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Regional Business Services Organisation Procurement and Logistics Service · Northern Ireland
Incumbent: Focus Pharmaceuticals Ltd · Last contest: 60 bids
- Published value
- £78kvalue of a framework or DPS agreement; may be a ceiling
- Annual run-rate
- —framework or DPS value, not a run-rate
- Term
- Estimated end 14 Nov 2035 · start not published
- Reference
ocds-h6vhtk-0437e0
How to read the radar
- End date is the contract period end the buyer published on the notice (or on the lot). Where the notice gives only a duration, the end is estimated as the signature date (or, without one, the publication date) plus that duration, and the row says so. Contracts with neither are not on the radar; neither are contracts the buyer cancelled or terminated early.
- List or panel totals. When one total is repeated on every provider of an approved list or panel, it is shown on the row but never added to the GBP totals or used for a run-rate.
- Extension option means the notice publishes a renewal or option clause; the buyer may extend. Hiding these rows shows contracts without a published option, but does not establish that the buyer will procure them again.
- Incumbent is the supplier named on the award behind the contract. A panel (several suppliers on one award) is shown as a panel; no single incumbent is invented.
- Annual run-rate = published GBP value ÷ published term for a single supplier and a term of six months or more. Values linked to a framework or DPS have no run-rate until we can tell whether they are a ceiling or a contract. The annual sort ranks comparable values excluding VAT first; gross-only values remain visible on their rows. This is not actual annual spend.
- Counts are exact for the time-horizon and sector filters. A parent framework or DPS counts once; call-offs published by other buyers count separately. Where the parent cannot be identified, agreements stay separate and are marked as linked to a framework or DPS; check the source notice before treating their date or value as a single contract fact. With other filters, a result above 1,000 rows shows as “1,000+”.
- Notice source. Both portals are searched by default. Untick one to keep a single portal; the last tick stays on, so a search always has at least one source. The badge on a row names where the contract was published. A Contracts Finder row opens its contract page. Sector, region, buyer type, agreement type, extension and the annual sort apply to Find a Tender; a Contracts Finder row follows the end date, the value and the keyword.
- Source. Official UK procurement notices, reused under the Open Government Licence v3.0; the radar is rebuilt nightly. How we count: methodology.